Christopher J. Lord

1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
   2005/04/01 by Hannah Farmer, Nuala McCabe, Christopher J. Lord +14 · 37 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #DNA Repair Mechanisms #PARP inhibition in cancer therapy #CRISPR and Genetic Engineering
2. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
   2015/10/28 by Joaquin Mateo, Joaquı́n Mateo, Suzanne Carreira +57 · 14 citations
   Medicine · #Prostate Cancer Treatment and Research #PARP inhibition in cancer therapy #Prostate Cancer Diagnosis and Treatment
3. A decade of clinical development of PARP inhibitors in perspective
   2019/06/17 by J. Mateo, C.J. Lord, Christopher J. Lord +16 · 5 citations
   Engineering · Immunology and Microbiology · Medicine · #Integrated Circuits and Semiconductor Failure Analysis #PARP inhibition in cancer therapy #Toxin Mechanisms and Immunotoxins
4. Elucidating acquired PARP inhibitor resistance in advanced prostate cancer
   2024/11/21 by George Seed, Nick Beije, Wei Yuan +33 · 2 voices · 1 citation
   Medicine · #PARP inhibition in cancer therapy #Prostate Cancer Diagnosis and Treatment #Prostate Cancer Treatment and Research